ENDOMETRIAL SEROUS ADENOCARCINOMA
Clinical trials for ENDOMETRIAL SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation course could ease treatment burden for uterine cancer patients
Disease control Recruiting nowThis study is comparing a shorter course of internal radiation to the standard longer course for women with early-stage uterine cancer who have already had surgery. The main goal is to see if the shorter treatment works just as well at controlling the cancer while maintaining or …
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: University of Utah • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Breakthrough trial aims to outsmart aggressive uterine cancer
Disease control Recruiting nowThis study is testing if adding newer, faster-to-administer targeted drugs to standard chemotherapy works better for people with a specific type of advanced uterine cancer (HER2-positive). It will involve 360 participants who have not had prior chemotherapy. The main goal is to s…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Blood test trial aims to predict uterine Cancer's return
Knowledge-focused Recruiting nowThis study is testing whether simple blood tests, called liquid biopsies, can predict if endometrial (uterine) cancer will come back after treatment. Researchers will collect blood samples from 1,000 women with endometrial cancer at different points during their treatment to trac…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC